Why Interventional Cardiologists Get Sued: The Cath Lab, the Perforation, and the Door-to-Balloon Clock

By John Mahoney · June 2026 · 8 min read

Interventional cardiology is the rare specialty that is both high-frequency and high-severity. The cath lab generates an enormous volume of invasive procedures on the sickest patients in the hospital, often emergently, and every one of them carries a small but real chance of a catastrophic complication — a coronary that tears, a heart that fills with blood, an artery that bleeds into the retroperitoneum. Layer in the time-critical STEMI clock and the contested question of whether a stent was even indicated, and you have a specialty where a defensible complication and a paid claim can look almost identical on the surface. An attorney who screens these files like a routine procedural case will miss where the liability actually lives. This guide explains where interventional-cardiology risk concentrates, the cannot-miss failures behind it, and what separates a strong case from a weak one — for plaintiff and defense med-mal attorneys.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. The patterns below draw on closed-claims literature, registry data, and cardiology practice guidelines that span different eras and definitions; treat them as directional, verify against the controlling jurisdiction, and value any individual case on its own record.

The Frequency-and-Severity Reality

Cardiology consistently ranks among the higher-risk specialties for malpractice exposure. In the widely cited Jena physician-malpractice analysis, cardiology sat above the all-specialty average annual claim frequency, and within cardiology the invasive and interventional subset carries the heaviest exposure because it pairs that frequency with procedures that can kill or disable in minutes. The cumulative career risk for an interventional cardiologist is high — physicians in higher-risk specialties commonly face a claim well before the end of their careers — and the procedural volume in a busy lab means the annual exposure stays elevated year after year.

Severity is where this specialty separates itself. Cardiology indemnity payments commonly run above the all-specialty average, and the catastrophic-outcome cases — death, anoxic brain injury, dialysis-dependent renal failure, limb loss — sit at the top of the damages distribution. A coronary perforation that progresses to tamponade and arrest, a delayed STEMI reperfusion that leaves a large infarct and heart failure, or an access-site bleed that is recognized too late can each produce a seven-figure claim. The screening lesson is that interventional-cardiology files have a high floor and a very high ceiling: most complications are recognized procedural risks, but a meaningful subset turns on a recognition-and-rescue failure or an indication dispute that dramatically raises the value.

The Dominant Allegation Types

Interventional-cardiology claims cluster into a procedural-complication group and a judgment group, with an informed-consent thread running through both:

• Improper performance of a procedure — the largest category by count: coronary artery perforation and dissection, cardiac tamponade, vascular access-site injury, and device or wire complications during catheterization and PCI.
• Failure to timely diagnose, treat, or reperfuse — the time-critical category, dominated by delayed reperfusion and prolonged door-to-balloon time in STEMI, and by failure to recognize and rescue an evolving post-procedure complication. These commonly carry the highest severity.
• Improper management of a known complication — the complication occurred within accepted risk, but the alleged negligence is the delayed or inadequate response to it (tamponade, retroperitoneal hemorrhage, stent thrombosis).
• Lack of informed consent / improper indication — central to the elective-PCI and "unnecessary stent" claims, where the dispute is whether the procedure was indicated and whether alternatives and risks were disclosed.
• Medication errors — anticoagulant and antiplatelet dosing around PCI, and the discharge antiplatelet regimen that, if mismanaged, drives stent thrombosis.

The structural point: by count, interventional cardiology is a procedural specialty, but by dollars, the time-critical reperfusion failures and the indication disputes punch far above their share. Any intake should be triaged first on which side of that line it sits, because the merit analysis, the experts, and the damages differ sharply.

The Cannot-Miss Conditions and Failures

The conditions and failures that drive interventional-cardiology litigation are:

• Coronary artery perforation and dissection leading to cardiac tamponade. The highest-acuity intra-procedural exposure. The recurring failure is not always the perforation itself — a known risk of wire, balloon, and atherectomy work — but the delayed recognition of tamponade and the slow escalation to pericardiocentesis, reversal, or surgical backup.
• Acute and subacute stent thrombosis — an abrupt, often catastrophic re-occlusion. Claims frequently turn on suboptimal stent deployment, premature discontinuation of dual antiplatelet therapy, or inadequate discharge instructions and follow-up.
• Vascular access-site complications — retroperitoneal hemorrhage from a high femoral stick, pseudoaneurysm, arteriovenous fistula, and limb ischemia. The decisive failure is usually delayed recognition of a concealed bleed in a hypotensive post-cath patient.
• Contrast-induced nephropathy and contrast reactions — failure to assess renal risk, hydrate, limit contrast volume, or recognize and treat an acute allergic or anaphylactoid reaction, sometimes producing dialysis-dependent renal failure.
• Delayed reperfusion / prolonged door-to-balloon time in STEMI — a guideline-anchored, clock-driven claim where a measurable delay maps directly to a larger infarct and worse outcome.
• Inappropriate or medically unnecessary stenting — elective PCI of a lesion that did not meet indication criteria, raising both negligence and informed-consent theories.
• Missed post-procedure complications — failure to monitor for and recognize tamponade, bleeding, arrhythmia, contrast nephropathy, or stent thrombosis in the hours after the case.

For the procedural side, the single most actionable screening question is the recognition-and-rescue question: once the complication occurred, how fast was it recognized and how appropriate was the response? Many of these complications are accepted procedural risks; the case is usually built on the delay, not the event. For the judgment side, the decisive questions are whether the door-to-balloon clock and the stent indication are documented and defensible.

The Contributing Factors That Drive Payouts

Across interventional-cardiology closed claims, the recurring contributing factors are:

• Technical skill / improper performance of a procedure — the most common error category, encompassing perforation, dissection, and access-site injury during catheterization and PCI. The complication alone rarely settles the case; the surrounding judgment usually does.
• Clinical judgment / recognition and rescue — the costliest factor: delayed recognition of tamponade, of a concealed retroperitoneal bleed, or of stent thrombosis, and slow escalation to the rescue maneuver. This is where a known complication becomes a paid claim.
• Indication and informed consent — failure to document a clear indication for elective PCI, to disclose the material risks, or to offer alternatives such as optimal medical therapy. The "unnecessary stent" theory lives here.
• Systems and timing — the door-to-balloon process for STEMI: activation, transfer, lab readiness, and the documented timeline that either defends or indicts the reperfusion delay.
• Medication and follow-up management — peri-procedural anticoagulation, the discharge antiplatelet regimen, and the follow-up plan whose breakdown drives subacute stent thrombosis.
• Documentation — incomplete records of consent, indication, intra-procedure events, contrast volume and renal risk, and the post-procedure monitoring that weaken the defense.

Two of these are interventional-cardiology-specific levers. The first is the recognition-and-rescue record: in a perforation or access-bleed case, the line between a defensible file and a paid claim is almost always the documented interval between the first abnormal vital sign and the rescue intervention. The second is the indication-and-timing record: in an elective-PCI case the chart must show why the stent was indicated, and in a STEMI case it must show the door-to-balloon timeline. Documentation rarely creates liability here, but it consistently decides whether the complication reads as accepted risk or negligence.

Strong Case vs. Weak Case in Interventional Cardiology Malpractice

The same factors grade the file, and the framing is useful to both sides.

What makes an interventional-cardiology case strong (plaintiff) / dangerous (defense)

• A coronary perforation or access-site bleed where the vital signs were trending for a meaningful interval before tamponade or hemorrhage was recognized, with a documented delay to pericardiocentesis, reversal, or transfusion — a clean recognition-and-rescue failure.
• A STEMI with a door-to-balloon time well outside the guideline window, with no documented justification, mapped to a larger infarct and resulting heart failure — a strong causation chain.
• An elective stent placed in a lesion that did not meet indication criteria, with absent or generic informed consent that omitted optimal medical therapy as an alternative.
• Subacute stent thrombosis following suboptimal deployment, premature antiplatelet discontinuation, or a discharge plan with no clear adherence and follow-up instructions.

What makes an interventional-cardiology case weak (plaintiff) / defensible (defense)

• A recognized complication — perforation, dissection, contrast reaction — that was promptly identified and appropriately rescued, with the timeline documented in the procedure and nursing records.
• A STEMI reperfused within the guideline door-to-balloon window, or a documented, legitimate reason for any delay (transfer, atypical presentation, cardiac arrest), framing the outcome as disease rather than negligence.
• An elective PCI with a documented indication meeting accepted criteria and an informed-consent record that disclosed the material risks and the medical-therapy alternative.
• A patient whose record shows non-adherence to antiplatelet therapy, missed follow-up, or refusal of recommended care that drove the bad outcome.

Interventional cardiology rewards a fast triage. On the procedural side, the case lives or dies on the recognition-and-rescue interval, not on whether a complication occurred at all. On the judgment side, it turns on the door-to-balloon clock and the documented indication for the stent. Whichever side you are on, grading the file means matching the right model to the right claim and pressure-testing the expert — the interventionalist on technique, the timing expert on reperfusion — who will carry it.

Bottom Line

Interventional cardiologists get sued often and they get sued for high stakes, because the cath lab combines enormous procedural volume with the sickest patients and the least margin for delay. Most of the complications that come — perforation, dissection, access-site bleeding, contrast injury — are recognized risks of invasive work, which is exactly why these cases so rarely turn on whether the event happened and so often turn on what happened next. The cannot-miss facts are the unrecognized tamponade, the concealed retroperitoneal bleed, the stent placed without a defensible indication, the antiplatelet plan that collapsed into thrombosis, and the door-to-balloon clock that ran too long. Whether you are screening these cases for the plaintiff or defending them, triage first to the right model — procedural complication or clinical judgment — and grade the file on the recognition-and-rescue interval, the indication record, and the documented timeline, not on the severity of the injury alone.

Questions? Contact us at [email protected] or (856) 979-6525

🔎 Screening a case in a different specialty? Browse all 70 specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →